Table of Contents Table of Contents
Previous Page  258 / 1082 Next Page
Information
Show Menu
Previous Page 258 / 1082 Next Page
Page Background

S245

ESTRO 36 2017

_______________________________________________________________________________________________

Conclusion

A real-time 3D tumor motion monitoring method was

established and validated in experiments and simulations

using known Calypso-recorded liver tumor motion. The

method is fully automatic and can be used for arbitrarily

shaped fiducial markers in the thorax or abdomen on a

conventional linac without additional time or hardware.

The internal position estimation can also be performed for

non-coplanar fields where there is no room to deploy the

kV imaging system.

OC-0465 Organ preservation for rectal cancer: the

GRECCAR 2 randomized phase III trial

V. Vendrely

1

, P. Rouanet

2

, J.J. Tuech

3

, H. Mosnier

4

, B.

Lelong

5

, M. Rivoire

6

, J.L. Faucheron

7

, M. Jafari

8

, G.

Portier

9

, B. Meunier

10

, B. Sastre

11

, M. Prudhomme

12

, F.

Marchal

13

, M. Pocard

14

, D. Pezet

15

, A. Rullier

16

, J.

Asselineau

17

, A. Doussau

17

, E. Rullier

1

1

CHU de Bordeaux, Gironde, Pessac, France

2

Institut Regional du Cancer Montpellier, Herault,

Montpellier, France

3

CHU Charles Nicolle, Seine-Maritime, Rouen, France

4

Groupe Hospitalier Diaconesses Croix Saint-Simon,

Paris, Paris, France

5

Département de Chirurgie Oncologique- Institut Paoli

Calmette, Bouches-du-Rhone, Marseille, France

6

Département de Chirurgie Oncologique- Centre Léon

Bérard, Rhone, Lyon, France

7

Service de Chirurgie Digestive- Hôpital A. Michallon,

Isere, Grenoble, France

8

Centre Oscar Lambret, Nord, Lille, France

9

Hopital Purpan - Pavillon Dieulafoy, Haute-Garonne,

Toulouse, France

10

CHU Pontchaillou, Ille-et-Vilaine, Rennes, France

11

CHU Timone, Bouches-du-Rhone, Marseille, France

12

Hôpital Universitaire Carémeau, Gard, Nimes, France

13

Centre Alexis Vautrin, Meurthe-et-Moselle, Nancy,

France

14

Hopital Lariboisiere, Paris, Paris, France

15

CHU Hotel-Dieu, Puy-de-Dome, Clermont-Ferrand,

France

16

CHU de Bordeaux- Hopital Pellegrin, Gironde,

Bordeaux, France

17

CHU de Bordeaux- USMR, Gironde, Bordeaux, France

Purpose or Objective

The objective was to compare local excision (LE) and total

mesorectal excision (TME) in patients with a good response

after radiochemotherapy for low rectal cancer.

Material and Methods

Patients with T2-T3 low rectal carcinoma, maximum size

4 cm, received neoadjuvant radiochemotherapy. Good

clinical responders (residual tumor ≤ 2 cm) were

randomized between LE and TME. In the LE group, a

completion TME was required if ypT2-3. The primary end

point was a composite outcome including death,

recurrence, morbidity and after-effects at 2 years.

Secondary outcomes were pathologic response, 3-year

local recurrence and survival.

Results

A hundred forty eight good clinical responders to

radiochemotherapy were randomized, 3 were excluded

and 145 were analyzed: 74 in the LE group and 71 in the

TME group. In the LE group, 26 patients had a completion

TME. At 2 years, significant events occurred in 56% in the

LE group and 48% in the TME group (p=0.320). In intention-

to-treat analysis, there was no difference between LE and

TME in all components of the composite outcome. Per

protocol analysis showed a lower morbidity

(11%/21%/48%,p=0.001)

and

fewer

after-effects

(17%/29%/62%,p<0.001) according to type of surgery LE,

TME and completion TME. Pathologic results showed a low

rate of positive lymph nodes in ypT0-1 (0%) and ypTx/cN0

(2%). 3-year local recurrence (5%) and overall survival

(92%) were similar between LE and TME groups.

Conclusion

LE is oncologically safe as compared to TME. Globally it is

not superior to TME, due to a high rate of completion TME

that increases morbidity and after-effects. A better

patient selection removing unnecessary completion TME

(ypT2/cN0) will improve the strategy.

OC-0466 Brachytherapy for conservative treatment of

penile carcinoma: prognostic factors and outcome

A. Escande

1

, C. Haie-Meder

1

, R. Mazeron

1

, P. Castelnau-

Marchand

1

, P. Maroun

1

, A. Cavalcanti

2

, F. Marsolat

1

, K.

Doyeux

1

, R. De Crevoisier

3

, F. Martinetti

1

, I. Dumas

1

, E.

Deutsch

1

, C. Chargary

1

1

Gustave Roussy Cancer Campus, Brachytherapy Unit-

Radiation Oncology, Villejuif, France

2

Gustave Roussy Cancer Campus, Department of Surgery,

Villejuif, France

3

Eugene Marquis Cancer Center, Radiation Oncology,

Rennes, France

THIS ABSTRACT FORMS PART OF THE MEDIA PROGRAMME

AND WILL BE AVAILABLE ON THE DAY OF ITS

PRESENTATION TO THE CONFERENCE.

OC-0467 Investigating reporting-and-learning systems

of Irish radiation therapy: Can standards be improved?

K. Dowling

1

, C. Poole

1

, L. Mullaney

1

, S. Barrett

1

1

Trinity College Dublin, Discipline of Radiation Therapy,

Dublin, Ireland

Purpose or Objective

Wide variation exists between event (incidents and near-

misses) reporting-and-learning systems utilised in the field

of radiation oncology. Due to the high potential for error